PRICE T ROWE ASSOCIATES INC /MD/

Holdings History for IGM Biosciences, Inc. - COMMON STOCK (IGMS)

Symbol: IGMS on Nasdaq
Investment type: Equity - Shares of Stock
Class: COMMON STOCK
Latest Disclosed Ownership: 65.9K shares
Security Ownership: 0.2%

Shares, Excluding Options vs Price

Value, Excluding Options

T. Rowe Price Associates, Inc. ownership in IGM Biosciences, Inc. COMMON STOCK (IGMS)

2025-02-07 - T. Rowe Price Associates, Inc. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 65.9K shares of IGM Biosciences, Inc. COMMON STOCK (IGMS). This represents 0.2% percent ownership of the company. In their previous filing dated 2025-02-14, PRICE T ROWE ASSOCIATES INC /MD/ had reported owning 3.57M shares, indicating a decrease of -98.2% percent.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
T. Rowe Price Associates, Inc.	0.2%	-93.6%	$88.4K	65.9K	-3,503,059	-98.2%	$1.34	13G/A	1/31/2025	7 Feb 2025 11:55:05
T. Rowe Price Associates, Inc.	10.5%		$4.78M	3.57M			$1.34	13G/A	12/31/2024	14 Feb 2025 09:44:10

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
12/31/2024	0%	0%	$21.8M	3.57M	-445,260	-11.1%	$6.11	Q4 2024
9/30/2024	0.01%	0%	$66.4M	4.01M	-60,832	-1.49%	$16.54	Q3 2024
6/30/2024	0%	+0%	$28M	4.08M	+187,068	+4.81%	$6.87	Q2 2024
3/31/2024	0%	+0%	$37.5M	3.89M	+628,001	+19.3%	$9.65	Q1 2024
12/31/2023	0%	+0%	$27.1M	3.26M	+17,307	+0.53%	$8.31	Q4 2023
9/30/2023	0%	+0%	$27.1M	3.24M	+11,845	+0.37%	$8.35	Q3 2023
6/30/2023	0%	+0%	$29.8M	3.23M	+1,109,995	+52.3%	$9.23	Q2 2023
3/31/2023	0%	0%	$29.1M	2.12M	-85,532	-3.88%	$13.74	Q1 2023
12/31/2022	0.01%	0%	$37.5M	2.21M	-11,359	-0.51%	$17.01	Q4 2022
9/30/2022	0.01%	0%	$50.4M	2.22M	-405,107	-15.4%	$22.74	Q3 2022
6/30/2022	0.01%	+0%	$47.3M	2.62M	+376,832	+16.8%	$18.03	Q2 2022
3/31/2022	0.01%	0%	$60M	2.25M	-125,234	-5.28%	$26.73	Q1 2022
12/31/2021	0.01%	+0%	$69.5M	2.37M	+13,811	+0.59%	$29.33	Q4 2021
9/30/2021	0.01%	+0%	$155M	2.36M	+371,393	+18.7%	$65.76	Q3 2021
6/30/2021	0.02%	+0%	$165M	1.99M	+189,760	+10.6%	$83.20	Q2 2021
3/31/2021	0.01%	+0%	$138M	1.8M	+467,527	+35.2%	$76.69	Q1 2021
12/31/2020	0.01%	+0%	$117M	1.33M	+460,573	+53%	$88.29	Q4 2020
9/30/2020	0.01%	0%	$64.1M	868K	-39,017	-4.3%	$73.81	Q3 2020
6/30/2020	0.01%	+0%	$66.2M	907K	+88,926	+10.9%	$73.00	Q2 2020
3/31/2020	0.01%	0%	$45.9M	818K	-99,219	-10.8%	$56.15	Q1 2020
12/31/2019	0%	+0%	$35M	918K	+102,242	+12.5%	$38.16	Q4 2019
9/30/2019	0%	+0%	$14.5M	815K	+815,279	NEW	$17.75	Q3 2019

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.